Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1977 1
1978 1
1979 1
1980 3
1981 3
1982 2
1983 3
1984 4
1985 3
1986 5
1987 2
1988 3
1989 1
1990 2
1991 3
1992 4
1993 4
1994 6
1995 4
1996 6
1997 6
1998 6
1999 5
2000 7
2001 3
2002 6
2003 8
2004 5
2005 6
2006 6
2007 3
2008 12
2009 3
2010 6
2011 6
2012 5
2013 9
2014 4
2015 3
2016 5
2017 2
2018 3
2019 7
2020 4
2021 4
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer.
Di Modica M, Gargari G, Regondi V, Bonizzi A, Arioli S, Belmonte B, De Cecco L, Fasano E, Bianchi F, Bertolotti A, Tripodo C, Villani L, Corsi F, Guglielmetti S, Balsari A, Triulzi T, Tagliabue E. Di Modica M, et al. Among authors: balsari a. Cancer Res. 2021 Apr 15;81(8):2195-2206. doi: 10.1158/0008-5472.CAN-20-1659. Epub 2021 Jan 22. Cancer Res. 2021. PMID: 33483370 Free article.
HER2 as a target for breast cancer therapy.
Tagliabue E, Balsari A, Campiglio M, Pupa SM. Tagliabue E, et al. Among authors: balsari a. Expert Opin Biol Ther. 2010 May;10(5):711-24. doi: 10.1517/14712591003689972. Expert Opin Biol Ther. 2010. PMID: 20214497 Review.
HER2 as a prognostic factor in breast cancer.
Ménard S, Fortis S, Castiglioni F, Agresti R, Balsari A. Ménard S, et al. Among authors: balsari a. Oncology. 2001;61 Suppl 2:67-72. doi: 10.1159/000055404. Oncology. 2001. PMID: 11694790 Review.
Exploiting poly(I:C) to induce cancer cell apoptosis.
Bianchi F, Pretto S, Tagliabue E, Balsari A, Sfondrini L. Bianchi F, et al. Among authors: balsari a. Cancer Biol Ther. 2017 Oct 3;18(10):747-756. doi: 10.1080/15384047.2017.1373220. Epub 2017 Sep 7. Cancer Biol Ther. 2017. PMID: 28881163 Free PMC article. Review.
Aerosol Delivery in the Treatment of Lung Cancer.
Storti C, Le Noci V, Sommariva M, Tagliabue E, Balsari A, Sfondrini L. Storti C, et al. Among authors: balsari a. Curr Cancer Drug Targets. 2015;15(7):604-12. doi: 10.2174/1568009615666150602143751. Curr Cancer Drug Targets. 2015. PMID: 26033086 Review.
Dansyl C-glucoside as a novel agent against endotoxic shock.
La Ferla B, Spinosa V, D'Orazio G, Palazzo M, Balsari A, Foppoli AA, Rumio C, Nicotra F. La Ferla B, et al. Among authors: balsari a. ChemMedChem. 2010 Oct 4;5(10):1677-80. doi: 10.1002/cmdc.201000282. ChemMedChem. 2010. PMID: 20726031 No abstract available.
191 results